The three-dimensional (3D) structure of the intrinsically dimeric insulin receptor bound to its ligand, insulin, was determined by electron cryomicroscopy. Gold-labeled insulin served to locate the insulin-binding domain. The 3D structure was then fitted with available known high-resolution domain substructures to obtain a detailed contiguous model for this heterotetrameric transmembrane receptor. The 3D reconstruction indicates that the two alpha subunits jointly participate in insulin binding and that the kinase domains in the two beta subunits are in a juxtaposition that permits autophosphorylation of tyrosine residues in the first step of insulin receptor activation.
The imaging of biological macromolecules at high resolution is predicated on the use of imaging modalities that combine a sufficiently high signal-to-noise ratio (S/N) to observe the desired detail with a sufficiently low dose not to have perturbed the structure at the resolution of that detail. For 3D structure determination the S/N has to be sufficiently high to permit the accurate position and orientation determination for individual molecules or assemblies.For 2D crystal specimens the position is determined a priori by the lattice, orientation by the externally chosen tilt of the specimen, and signal-to-noise in a single unit cell enhanced by the translocational redundancy of the many unit cells of the crystal. This is close to an ideal specimen, which has permitted imaging with resolutions of 3.4 À at doses of 20-35 e/Â2[l]. Specimens with high internal symmetry, icosahedral or helical structures, are examples which confer intermediate structural redundancies to assist in reducing the requires electron dose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.